The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Injectable Drug Delivery Devices Market Increase Between 2026 And 2030?
The injectable drug delivery devices market has seen significant growth over recent years. It is anticipated to increase from $54.3 billion in 2025 to $58.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to the rising incidence of chronic diseases, the broadening scope of biologics and biosimilars, an increase in hospital-based injectable treatments, enhancements in sterile manufacturing practices, and the wider availability of injection devices.
The injectable drug delivery devices market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $79.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This forecasted growth is primarily driven by an increasing preference for self-administration devices, the escalating need for personalized drug delivery, the expansion of biologic drug development pipelines, increasing capital allocation towards smart injection technologies, and the wider integration of home healthcare solutions. Key trends foreseen during this period involve a greater embrace of prefilled and safety syringes, a heightened demand for autoinjectors and pen injectors, the expanding application of injectable therapies in home settings, the proliferation of wearable and implantable infusion pumps, and an intensified commitment to precise dosing and patient well-being.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp
Which Core Factors Are Supporting The Expansion Of The Injectable Drug Delivery Devices Market?
The increasing occurrence of chronic illnesses is anticipated to fuel expansion in the injectable drug delivery devices market. A chronic disease is defined as an ailment persisting for three months or longer, potentially worsening over time. These devices provide a dependable and easy way to administer medications for prolonged durations. Such devices can improve patients’ compliance with their prescribed treatment plans, leading to efficient management of chronic conditions and, consequently, improved health results. For example, in June 2024, data from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) had been diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This represented an 18% increase from 3,065,825 cases recorded in 2022. Consequently, the growing incidence of chronic diseases is propelling the expansion of the injectable drug delivery devices market into the future.
How Is The Injectable Drug Delivery Devices Market Distributed Across Key Segments?
The injectable drug delivery devices market covered in this report is segmented –
1) By Type: Syringes, Injectors, Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
Subsegments:
1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes
2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors
3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps
Which Trends Are Guiding The Development Of The Injectable Drug Delivery Devices Market?
Major companies operating in the injectable drug delivery devices market are concentrating on creating sophisticated solutions, including wearable and smart injectors, with the aim of boosting patient ease, improving compliance, and facilitating the self-administration of intricate treatments. These innovative wearable and smart injector systems are engineered to administer precise medication doses, encompassing biologics and high-volume formulations, concurrently lessening discomfort, lowering the potential for user mistakes, and elevating the comprehensive treatment journey. As an illustration, during January 2025, Becton, Dickinson and Company, a medical technology firm based in the US, unveiled several cutting-edge devices, including the BD Accuspray Nasal Spray System, BD Hylok Glass Prefillable Syringe, BD Effivax Glass Prefillable Syringe, BD Libertas Wearable Injector, BD Evolve On-body Injector, BD Physioject Disposable Autoinjector, and BD Vystra Disposable Pen. These offerings incorporate designs that are simple for patients to use for self-administration, provide exact and reliable dosing for biologics and vaccines, maintain compatibility with various drug formulations, and come in wearable designs that facilitate the delivery of large volumes, all the while guaranteeing hygiene and security via their disposable parts. This introduction highlights the industry’s progression towards sophisticated, patient-focused injectable drug delivery systems, which are intended to enhance compliance, improve comfort, and optimize therapeutic results.
Who Are The Companies Shaping The Injectable Drug Delivery Devices Market Landscape?
Major companies operating in the injectable drug delivery devices market are Becton Dickinson and Company, Baxter International, Gerresheimer AG, Catalent Inc., Antares Pharma, Owen Mumford, West Pharmaceutical Services Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co. Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk
Access The Complete Injectable Drug Delivery Devices Market Report:
Which Region Holds The Largest Share In The Injectable Drug Delivery Devices Market?
North America was the largest region in the injectable drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Injectable Drug Delivery Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Injectable Drug Delivery Devices Market 2026, By The Business Research Company
Glucose Biosensors Market Report 2026
https://www.thebusinessresearchcompany.com/report/glucose-biosensors-global-market-report
Disposable Medical Sensors Market Report 2026
https://www.thebusinessresearchcompany.com/report/disposable-medical-sensors-global-market-report
Disposable Medical Devices Sensors Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model